NIH « Science and Enterprise

National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
about 21 hours ago
New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
about 21 hours ago
A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
about 21 hours ago
New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
about 1 day ago
A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
about 2 days ago

NIH Assessing Home Covid-19 Diagnostic with App

By Alan, on March 1st, 2021%

A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-19 diagnostics for widespread use. . . . → Read More: NIH Assessing Home Covid-19 Diagnostic with App

U.S. Supports Home Smartphone Covid-19 Test

By Alan, on February 1st, 2021%

The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone. . . . → Read More: U.S. Supports Home Smartphone Covid-19 Test

Antibody Therapy Shown to Prevent Covid-19 Disease

By Alan, on January 26th, 2021%

Clinical trial results show a combination of synthetic antibodies designed to treat Covid-19 infections can also prevent contracting the disease. . . . → Read More: Antibody Therapy Shown to Prevent Covid-19 Disease

Covid-19 Vaccine Shown Active Against Variants

By Alan, on January 25th, 2021%

Moderna Inc., developer of a vaccine to prevent Covid-19 disease, says lab test results show antibodies from the vaccine neutralize two recently found viral mutations. . . . → Read More: Covid-19 Vaccine Shown Active Against Variants

U.S. Rejoins WHO, Participates in Int’l Vaccine Project

By Alan, on January 21st, 2021%

In one of its first actions, the Biden administration rejoined the United States in the World Health Organization, reversing a policy of its predecessor. . . . → Read More: U.S. Rejoins WHO, Participates in Int’l Vaccine Project

Antibodies Prevent Covid-19 Symptoms in Long-Term Care

By Alan, on January 21st, 2021%

A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections. . . . → Read More: Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Multi-Variant Covid-19 Vaccine in the Works

By Alan, on January 19th, 2021%

A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon. . . . → Read More: Multi-Variant Covid-19 Vaccine in the Works

Moderna Developing Flu, HIV, Nipah Vaccines

By Alan, on January 11th, 2021%

Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases. . . . → Read More: Moderna Developing Flu, HIV, Nipah Vaccines

Small Biz Grant Funds Heat-Stable Multi-Virus Vaccine

By Alan, on December 28th, 2020%

A biotechnology company is receiving a federal grant for a vaccine in freeze-dried form to prevent infections from Covid-19 and Ebola viruses. . . . → Read More: Small Biz Grant Funds Heat-Stable Multi-Virus Vaccine

Large Trial Testing Covid-19 Antibody Therapies

By Alan, on December 18th, 2020%

A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections. . . . → Read More: Large Trial Testing Covid-19 Antibody Therapies

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise